---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-005022"
form_type: "8-K"
ticker: "OBIO"
cik: "0001814114"
company_name: "Orchestra BioMed Holdings, Inc."
filed_at: "2023-01-25T23:59:59+00:00"
generated_at: "2026-06-20T09:39:28.965773+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Health Sciences Acquisitions 2 shareholders approve merger with Orchestra BioMed; closing expected Jan 2023

## Summary
- All 9 proposals approved at Jan 24 EGM, including Merger Agreement, Domestication, and Equity Incentive Plan.
- Business Combination with Orchestra BioMed to close in January 2023, subject to remaining conditions.
- Directors elected for New Orchestra: Eric Rose, Jason Aryeh, Pamela Connealy, Geoffrey Smith, David Hochman, Darren Sherman, Eric Fain.
- Vote results: 9.44M for (96.5% of voting) on Business Combination Proposal; quorum of 87.2% achieved.

## SEC filing metadata
- accession: 0001213900-23-005022
- form_type: 8-K
- ticker: OBIO
- cik: 0001814114
- company_name: Orchestra BioMed Holdings, Inc.
- filed_at: 2023-01-25T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1814114/000121390023005022/0001213900-23-005022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1814114/000121390023005022/ea172160-8k425_health2.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-005022
- JSON: https://secwatch.observer/filing/0001213900-23-005022.json
- Plain text: https://secwatch.observer/filing/0001213900-23-005022.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.